• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于直接经皮冠状动脉介入治疗的高危心肌梗死患者发生主要不良心脑血管事件的预测规则的制定与验证。

Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention.

机构信息

Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, BeiJing, People's Republic of China.

Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, People's Republic of China.

出版信息

Clin Interv Aging. 2022 Jul 18;17:1099-1111. doi: 10.2147/CIA.S358761. eCollection 2022.

DOI:10.2147/CIA.S358761
PMID:35880211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9307870/
Abstract

BACKGROUND AND AIMS

We aimed to develop a clinical prediction tool to improve the prognosis of major adverse cardiac and cerebrovascular events (MACCE) among high-risk myocardial infarction (MI) patients undergoing primary percutaneous coronary intervention (PCI).

METHODS

The present study was a prospective and observational study. A total of 4151 consecutive MI patients who underwent primary PCI at Fuwai Hospital in Beijing, China (January 2010 and June 2017) were enrolled. Forty-eight patients without follow-up data were excluded from the study. The pre-specified criteria (Supplementary Information 1) were chosen to enroll MI patients at high risk for MACCE complications after PCI.

RESULTS

The full model included seven variables, with a risk score of 160 points. Derivation and validation cohort models predicting MACCE had C-statistics of 0.695 and 0.673. The area under the curve (AUC) of the survival receiver operating characteristic curve (ROC) for predicting MACCE was 0.991 and 0.883 in the derivation and validation cohorts, respectively.

CONCLUSION

The predicted model was internally validated and calibrated in large cohorts of patients with high-risk MI receiving primary PCI to predict MACCE and showed modest accuracy in the derivation and validation cohorts.

摘要

背景与目的

我们旨在开发一种临床预测工具,以改善接受直接经皮冠状动脉介入治疗(PCI)的高危心肌梗死(MI)患者发生主要不良心脑血管事件(MACCE)的预后。

方法

本研究为前瞻性、观察性研究。共纳入 4151 例在北京阜外医院接受直接 PCI 的连续 MI 患者(2010 年 1 月至 2017 年 6 月)。排除 48 例无随访数据的患者。根据预设定标准(补充信息 1),选择 MI 患者接受 PCI 后发生 MACCE 并发症的高风险。

结果

全模型包括 7 个变量,风险评分 160 分。预测 MACCE 的推导和验证队列模型的 C 统计量分别为 0.695 和 0.673。预测 MACCE 的生存接收者操作特征曲线(ROC)的曲线下面积(AUC)在推导和验证队列中分别为 0.991 和 0.883。

结论

该预测模型在接受直接 PCI 的高危 MI 患者的大队列中进行了内部验证和校准,可预测 MACCE,在推导和验证队列中具有中等准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/5e5d65bd5a28/CIA-17-1099-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/bebd3ec5a90d/CIA-17-1099-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/a8cf6e700d3d/CIA-17-1099-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/e3ef422ed662/CIA-17-1099-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/5e5d65bd5a28/CIA-17-1099-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/bebd3ec5a90d/CIA-17-1099-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/a8cf6e700d3d/CIA-17-1099-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/e3ef422ed662/CIA-17-1099-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/9307870/5e5d65bd5a28/CIA-17-1099-g0004.jpg

相似文献

1
Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention.基于直接经皮冠状动脉介入治疗的高危心肌梗死患者发生主要不良心脑血管事件的预测规则的制定与验证。
Clin Interv Aging. 2022 Jul 18;17:1099-1111. doi: 10.2147/CIA.S358761. eCollection 2022.
2
Risk prediction score for the incidence of long-term cerebrovascular events among patients undergoing primary percutaneous coronary intervention: a retrospective real-world study.接受直接经皮冠状动脉介入治疗的患者发生长期脑血管事件的风险预测评分:一项回顾性真实世界研究。
Pol Arch Intern Med. 2022 Jan 28;132(1). doi: 10.20452/pamw.16088. Epub 2021 Sep 27.
3
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
4
Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions.J-CTO 延伸评分在预测慢性完全闭塞患者术前主要心脑血管不良事件中的推导和验证。
PLoS One. 2020 Sep 11;15(9):e0238640. doi: 10.1371/journal.pone.0238640. eCollection 2020.
5
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响:SYNTAX 试验(紫杉醇药物洗脱支架与心脏搭桥术的联合治疗)的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
6
[Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].[心肌梗死溶栓风险指数与接受经皮冠状动脉介入治疗的急性心肌梗死患者冠状动脉病变严重程度及长期预后的关系]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Nov 24;46(11):874-881. doi: 10.3760/cma.j.issn.0253-3758.2018.11.011.
7
Predictive value of ACEF II score for adverse prognosis in patients with coronary heart disease after percutaneous coronary intervention.ACEF II 评分对经皮冠状动脉介入治疗后冠心病患者不良预后的预测价值。
Postgrad Med J. 2023 Jun 15;99(1172):605-612. doi: 10.1136/postgradmedj-2022-141609.
8
Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention.PARIS 血栓风险评分对经皮冠状动脉介入治疗后 2 年死亡率的预测价值。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619853638. doi: 10.1177/1076029619853638.
9
[The value of SYNTAX score in predicting outcome patients undergoing percutaneous coronary intervention].[SYNTAX评分在预测接受经皮冠状动脉介入治疗患者预后中的价值]
Zhonghua Nei Ke Za Zhi. 2012 Jan;51(1):31-3.
10
Validating the Performance of 5 Risk Scores for Major Adverse Cardiac Events in Patients Who Achieved Complete Revascularization After Percutaneous Coronary Intervention.验证 5 种风险评分在经皮冠状动脉介入治疗后实现完全血运重建的患者中主要不良心脏事件的表现。
Can J Cardiol. 2019 Aug;35(8):1058-1068. doi: 10.1016/j.cjca.2019.02.017. Epub 2019 Feb 27.

引用本文的文献

1
Machine learning-based models for prediction of the risk of stroke in coronary artery disease patients receiving coronary revascularization.基于机器学习的模型预测接受冠状动脉血运重建的冠心病患者中风风险。
PLoS One. 2024 Feb 8;19(2):e0296402. doi: 10.1371/journal.pone.0296402. eCollection 2024.
2
Machine learning-based in-hospital mortality risk prediction tool for intensive care unit patients with heart failure.基于机器学习的心力衰竭重症监护病房患者院内死亡风险预测工具。
Front Cardiovasc Med. 2023 Apr 3;10:1119699. doi: 10.3389/fcvm.2023.1119699. eCollection 2023.

本文引用的文献

1
Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock.桡动脉入路可降低 ST 段抬高型心肌梗死合并心原性休克患者的死亡率。
Pol Arch Intern Med. 2021 May 25;131(5):421-428. doi: 10.20452/pamw.15886. Epub 2021 Mar 19.
2
Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死患者的工作时间和非工作时间。
Hellenic J Cardiol. 2021 May-Jun;62(3):212-218. doi: 10.1016/j.hjc.2021.01.011. Epub 2021 Feb 1.
3
Incidence and risk factors for stroke following percutaneous coronary intervention.
经皮冠状动脉介入治疗后中风的发生率及危险因素
Int J Stroke. 2020 Oct;15(8):909-922. doi: 10.1177/1747493020912607. Epub 2020 Apr 4.
4
Management of patients with acute ST-segment elevation myocardial infarction in Russian hospitals adheres to international guidelines.俄罗斯医院对急性ST段抬高型心肌梗死患者的管理遵循国际指南。
Open Heart. 2020 Jan 23;7(1):e001134. doi: 10.1136/openhrt-2019-001134. eCollection 2020.
5
Comparison of long-term mortality between living alone patients vs. living together patients with acute coronary syndrome treated with percutaneous coronary intervention.独居与非独居急性冠状动脉综合征行经皮冠状动脉介入治疗患者长期死亡率比较。
Eur Heart J Qual Care Clin Outcomes. 2020 Oct 1;6(4):332-337. doi: 10.1093/ehjqcco/qcaa011.
6
Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database.血管内影像学检查与非保护左主干 PCI 术后 12 个月死亡率:来自英国心血管介入学会数据库的分析。
JACC Cardiovasc Interv. 2020 Feb 10;13(3):346-357. doi: 10.1016/j.jcin.2019.10.007.
7
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.替格瑞洛联合或不联合阿司匹林用于 PCI 术后高危患者。
N Engl J Med. 2019 Nov 21;381(21):2032-2042. doi: 10.1056/NEJMoa1908419. Epub 2019 Sep 26.
8
Radial Approach Expertise and Clinical Outcomes of Percutanous Coronary Interventions Performed Using Femoral Approach.经股动脉途径进行经皮冠状动脉介入治疗的桡动脉途径专业技能与临床结果。
J Clin Med. 2019 Sep 18;8(9):1484. doi: 10.3390/jcm8091484.
9
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
10
Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI.血红蛋白水平联合 CAMI-STEMI 评分对 PCI 治疗后急性 ST 段抬高型心肌梗死患者 MACCE 的预测价值。
Biomed Res Int. 2019 Jul 22;2019:8534752. doi: 10.1155/2019/8534752. eCollection 2019.